Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice-Reference-Cited by-同舟云学术

Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice

Published:2013-12-05 Issue:12 Volume:9 Page:e1003774
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Hatesuer Bastian,Bertram Stephanie,Mehnert Nora,Bahgat Mahmoud M.,Nelson Peter S.,Pöhlman Stefan,Schughart Klaus

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference39 articles.

1. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives;AC Hurt;Lancet Infect Dis,2012

2. Activation of influenza A viruses by trypsin treatment;HD Klenk;Virology,1975

3. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide;SG Lazarowitz;Virology,1975

4. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease;A Stieneke-Grober;EMBO J,1992

5. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein;H Kido;J Biol Chem,1992

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses;Virology;2024-12

2. Gene editing of pigs to control influenza A virus infections;Emerging Microbes & Infections;2024-08-24

3. Pigs lacking TMPRSS2 displayed fewer lung lesions and reduced inflammatory response when infected with influenza A virus;Frontiers in Genome Editing;2024-05-31

4. Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19;Journal of Virology;2024-05-14

5. Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals;Antiviral Research;2024-05